Predict your next investment

Private Equity

See what CB Insights has to offer

Investments

145

Portfolio Exits

61

About Heights Capital Management

Heights Capital Management, founded in 1996 and based in San Francisco, CA, is a private equity firm focusing on PIPE investment (private investments in public equity) in emerging growth companies. The firm typically invests in healthcare and technology companies.

Heights Capital Management Headquarters Location

101 California Street # 3250

San Francisco, California, 94111,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Heights Capital Management News

Modulus Discovery Closes $20.4M USD Series C Funding

Mar 4, 2022

Modulus Discovery, Inc. , a Boston, MA- and Tokyo, Japan-based preclinical-stage computation-driven drug discovery company, closed a Series C funding round in the amount of 2.34B JPY (approximately $20.4M USD). Backers included Green Coinvest Investment Limited Partnership., SBI Group., Heights Capital Management, Inc., and existing shareholders including UTokyo Innovation Platform Co., Ltd., JAFCO Group Co., Ltd., Keio Innovation Initiative, Inc. (KII), and Fast Track Initiative, Inc. Modulus has raised to date, a total of 5.86B JPY (approximately $51M USD). The company will use the proceeds to further its portfolio of R&D programs driven by its proprietary computational drug discovery platform and globally networked operational model. In addition to accelerating its existing pipeline of over 10 R&D programs, Modulus aims to increase its business value through expansion of its platform infrastructure, collaborations with industry and academic partners, and increase personnel in R&D and operations to deliver innovative drug candidates through clinical partnerships and additional drug discovery collaborations. Led by S. Roy Kimura, Ph.D., Co-founder and CEO, Modulus Discovery is a preclinical-stage computation-driven drug discovery company pursuing its proprietary portfolio of small-molecule discovery programs and collaborations through integration of its core biology insights, discovery platform, and scalable networked operations. Modulus is focused on the efficient delivery of medicines for patients and their families with unmet medical needs in areas including oncology, chronic inflammation / immune disorders, and rare genetic conditions. FinSMEs 04/03/2022

Heights Capital Management Investments

145 Investments

Heights Capital Management has made 145 investments. Their latest investment was in Modulus Discovery as part of their Series C on March 3, 2022.

CBI Logo

Heights Capital Management Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

3/1/2022

Series C

Modulus Discovery

$20.37M

Yes

7

8/11/2021

PIPE

Claranova

$76.23M

Yes

2

2/25/2021

Series B

Cullgen

$50M

Yes

13

11/19/2020

PIPE

Subscribe to see more

$99M

Subscribe to see more

10

11/7/2012

Series E - II

Subscribe to see more

$99M

Subscribe to see more

10

Date

3/1/2022

8/11/2021

2/25/2021

11/19/2020

11/7/2012

Round

Series C

PIPE

Series B

PIPE

Series E - II

Company

Modulus Discovery

Claranova

Cullgen

Subscribe to see more

Subscribe to see more

Amount

$20.37M

$76.23M

$50M

$99M

$99M

New?

Yes

Yes

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

7

2

13

10

10

Heights Capital Management Portfolio Exits

61 Portfolio Exits

Heights Capital Management has 61 portfolio exits. Their latest portfolio exit was Antares Pharma on May 24, 2022.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

5/24/2022

Acq - P2P

$99M

5

6/8/2020

Take Private

$99M

Undisclosed Investors

1

12/10/2018

Acq - P2P

$99M

5

3/9/2018

Acq - P2P

Subscribe to see more

$99M

Subscribe to see more

10

8/2/2017

Merger

Subscribe to see more

$99M

Subscribe to see more

10

Date

5/24/2022

6/8/2020

12/10/2018

3/9/2018

8/2/2017

Exit

Acq - P2P

Take Private

Acq - P2P

Acq - P2P

Merger

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Acquirer

Undisclosed Investors

Subscribe to see more

Subscribe to see more

Sources

5

1

5

10

10

Heights Capital Management Acquisitions

1 Acquisition

Heights Capital Management acquired 1 company. Their latest acquisition was US LEC on November 21, 2003.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

11/21/2003

Other Venture Capital

$99M

$210M

Acquired

Date

11/21/2003

Investment Stage

Other Venture Capital

Companies

Valuation

$99M

Total Funding

$210M

Note

Acquired

Sources

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.